[go: up one dir, main page]

SE9801287D0 - Incorporation of active substances in carrier matrixes - Google Patents

Incorporation of active substances in carrier matrixes

Info

Publication number
SE9801287D0
SE9801287D0 SE9801287A SE9801287A SE9801287D0 SE 9801287 D0 SE9801287 D0 SE 9801287D0 SE 9801287 A SE9801287 A SE 9801287A SE 9801287 A SE9801287 A SE 9801287A SE 9801287 D0 SE9801287 D0 SE 9801287D0
Authority
SE
Sweden
Prior art keywords
incorporation
active substances
carrier matrixes
carrier
matrixes
Prior art date
Application number
SE9801287A
Other languages
English (en)
Swedish (sv)
Inventor
Marie-Louise Andersson
Catherine Boissier
Anne Marie Juppo
Anette Larsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9801287A priority Critical patent/SE9801287D0/xx
Publication of SE9801287D0 publication Critical patent/SE9801287D0/xx
Priority to TW088105268A priority patent/TW542724B/zh
Priority to ZA9902549A priority patent/ZA992549B/xx
Priority to ARP990101561A priority patent/AR019262A1/es
Priority to CA002327522A priority patent/CA2327522C/en
Priority to IDW20001991A priority patent/ID29286A/id
Priority to US09/297,440 priority patent/US6372260B1/en
Priority to HU0102305A priority patent/HUP0102305A3/hu
Priority to NZ507190A priority patent/NZ507190A/en
Priority to EP99924076A priority patent/EP1069890B1/en
Priority to EEP200000595A priority patent/EE200000595A/xx
Priority to PCT/SE1999/000583 priority patent/WO1999052507A1/en
Priority to ES99924076T priority patent/ES2267268T3/es
Priority to CZ20003784A priority patent/CZ20003784A3/cs
Priority to DE69931904T priority patent/DE69931904T2/de
Priority to JP2000543117A priority patent/JP2002511400A/ja
Priority to SK1411-2000A priority patent/SK14112000A3/sk
Priority to TR2000/02960T priority patent/TR200002960T2/xx
Priority to IL13863599A priority patent/IL138635A0/xx
Priority to SI9930906T priority patent/SI1069890T1/sl
Priority to PT99924076T priority patent/PT1069890E/pt
Priority to RU2000125873/14A priority patent/RU2208435C2/ru
Priority to DK99924076T priority patent/DK1069890T3/da
Priority to BR9909636-6A priority patent/BR9909636A/pt
Priority to CNB998050318A priority patent/CN1201728C/zh
Priority to PL99344077A priority patent/PL344077A1/xx
Priority to AT99924076T priority patent/ATE329580T1/de
Priority to AU40663/99A priority patent/AU744874B2/en
Priority to KR1020007011361A priority patent/KR100600691B1/ko
Priority to IS5656A priority patent/IS5656A/is
Priority to NO20005150A priority patent/NO329145B1/no
Priority to CY20061101138T priority patent/CY1105154T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Nozzles (AREA)
SE9801287A 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes SE9801287D0 (sv)

Priority Applications (32)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes
TW088105268A TW542724B (en) 1998-04-14 1999-04-02 Incorporation of active substances in carrier matrixes
ZA9902549A ZA992549B (en) 1998-04-14 1999-04-06 Incorporation of active substances in carrier matrixes.
ARP990101561A AR019262A1 (es) 1998-04-14 1999-04-06 Proceso para la preparacion de una formulacion que comprende una sustancia activa o sustancias activas asociadas con un portador, y formulacion preparadapor dicho proceso.
KR1020007011361A KR100600691B1 (ko) 1998-04-14 1999-04-09 활성 물질의 담체 매트릭스로의 결합
DE69931904T DE69931904T2 (de) 1998-04-14 1999-04-09 Einbau aktiver substanzen in trägermatrizen
TR2000/02960T TR200002960T2 (tr) 1998-04-14 1999-04-09 Taşıyıcı matrislere etken maddelerin eklenmesi.
US09/297,440 US6372260B1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
HU0102305A HUP0102305A3 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
NZ507190A NZ507190A (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes wherein an emulsion is contacted with a fluid gas using an anti-solvent technique
EP99924076A EP1069890B1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
EEP200000595A EE200000595A (et) 1998-04-14 1999-04-09 Toimeaine viimine kandjamaatriksisse
PCT/SE1999/000583 WO1999052507A1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
ES99924076T ES2267268T3 (es) 1998-04-14 1999-04-09 Incorporacion de sustancias activas en matrices vehiculo.
CZ20003784A CZ20003784A3 (cs) 1998-04-14 1999-04-09 Způsob inkorporace účinných látek do matric nosičů
CA002327522A CA2327522C (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
JP2000543117A JP2002511400A (ja) 1998-04-14 1999-04-09 担体マトリックスへの活性物質の組み込み
SK1411-2000A SK14112000A3 (sk) 1998-04-14 1999-04-09 Začlenenie účinných látok do matríc nosiča
IDW20001991A ID29286A (id) 1998-04-14 1999-04-09 Pemasukan zat-zat aktif pada matriks pembawa
IL13863599A IL138635A0 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
SI9930906T SI1069890T1 (sl) 1998-04-14 1999-04-09 Vkljucitev aktivnih substanc v matriko nosilca
PT99924076T PT1069890E (pt) 1998-04-14 1999-04-09 Incorporacao de substancias activas em matrizes veiculares
RU2000125873/14A RU2208435C2 (ru) 1998-04-14 1999-04-09 Внедрение активных веществ в матрицы носителей
DK99924076T DK1069890T3 (da) 1998-04-14 1999-04-09 Inkorporering af aktive substanser i bærematrikser
BR9909636-6A BR9909636A (pt) 1998-04-14 1999-04-09 Processo para a preparação de uma formulação, e, formulação
CNB998050318A CN1201728C (zh) 1998-04-14 1999-04-09 载体基质中活性物质的掺入
PL99344077A PL344077A1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
AT99924076T ATE329580T1 (de) 1998-04-14 1999-04-09 Einbau aktiver substanzen in trägermatrizen
AU40663/99A AU744874B2 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes
IS5656A IS5656A (is) 1998-04-14 2000-10-11 Innlimun virkra efna í burðarmatrixur
NO20005150A NO329145B1 (no) 1998-04-14 2000-10-13 Inkorporering av aktive substanser i baerermatriser
CY20061101138T CY1105154T1 (el) 1998-04-14 2006-08-11 Ενσωματωση δραστικων ουσιων σε μητρες ουσιων-φορεων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Publications (1)

Publication Number Publication Date
SE9801287D0 true SE9801287D0 (sv) 1998-04-14

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Country Status (31)

Country Link
US (1) US6372260B1 (xx)
EP (1) EP1069890B1 (xx)
JP (1) JP2002511400A (xx)
KR (1) KR100600691B1 (xx)
CN (1) CN1201728C (xx)
AR (1) AR019262A1 (xx)
AT (1) ATE329580T1 (xx)
AU (1) AU744874B2 (xx)
BR (1) BR9909636A (xx)
CA (1) CA2327522C (xx)
CY (1) CY1105154T1 (xx)
CZ (1) CZ20003784A3 (xx)
DE (1) DE69931904T2 (xx)
DK (1) DK1069890T3 (xx)
EE (1) EE200000595A (xx)
ES (1) ES2267268T3 (xx)
HU (1) HUP0102305A3 (xx)
ID (1) ID29286A (xx)
IL (1) IL138635A0 (xx)
IS (1) IS5656A (xx)
NO (1) NO329145B1 (xx)
NZ (1) NZ507190A (xx)
PL (1) PL344077A1 (xx)
PT (1) PT1069890E (xx)
RU (1) RU2208435C2 (xx)
SE (1) SE9801287D0 (xx)
SK (1) SK14112000A3 (xx)
TR (1) TR200002960T2 (xx)
TW (1) TW542724B (xx)
WO (1) WO1999052507A1 (xx)
ZA (1) ZA992549B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
AU2729101A (en) * 1999-12-21 2001-07-03 Rxkinetix, Inc. Particulate drug-containing products and method of manufacture
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
CN100478026C (zh) * 2001-09-28 2009-04-15 纽特休迪克斯公司 用于生物学组分的传递系统
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US6931888B2 (en) * 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
CA2523883C (en) * 2003-04-29 2012-01-03 Akzo Nobel N.V. Antisolvent solidification process
BRPI0409962A (pt) 2003-05-08 2006-04-25 Nektar Therapeutics Uk Ltd co-formulação particulada de uma substáncia ativa e um excipiente, composição farmacêutica ou nutricêutrica, produto farmacêutico ou nutricêutico, método para preparar uma co-formulação particulada de uma substáncia ativa e um excipiente, e, uso de uma substáncia ativa e um excipiente
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
WO2005022603A2 (en) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Low cost conductive containers manufactured from conductive loaded resin-based materials
GB0602637D0 (en) * 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
US20080095856A1 (en) * 2006-05-12 2008-04-24 Jacobson Gunilla B Encapsulated Nanoparticles for Drug Delivery
FR2900845B1 (fr) 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (en) 2006-10-19 2008-04-23 Gerhard, Markus Novel method for treating H.pylori infections
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
PT2425820E (pt) 2007-02-11 2015-08-04 Map Pharmaceuticals Inc Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) * 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
NZ233503A (en) * 1989-05-15 1991-06-25 Janssen Pharmaceutica Nv Substituted (thio)morpholinyl and piperazinyl alkylphenol ethers
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
WO1999052507A1 (en) 1999-10-21
TW542724B (en) 2003-07-21
JP2002511400A (ja) 2002-04-16
KR20010042660A (ko) 2001-05-25
NO20005150D0 (no) 2000-10-13
KR100600691B1 (ko) 2006-07-19
ZA992549B (en) 1999-10-14
EE200000595A (et) 2002-04-15
IL138635A0 (en) 2001-10-31
NO20005150L (no) 2000-12-08
AU4066399A (en) 1999-11-01
CA2327522A1 (en) 1999-10-21
US6372260B1 (en) 2002-04-16
SK14112000A3 (sk) 2001-07-10
AR019262A1 (es) 2002-02-13
AU744874B2 (en) 2002-03-07
ATE329580T1 (de) 2006-07-15
EP1069890A1 (en) 2001-01-24
DK1069890T3 (da) 2006-08-28
NO329145B1 (no) 2010-08-30
DE69931904D1 (de) 2006-07-27
RU2208435C2 (ru) 2003-07-20
CA2327522C (en) 2008-03-25
PL344077A1 (en) 2001-09-24
HUP0102305A2 (hu) 2001-12-28
EP1069890B1 (en) 2006-06-14
ID29286A (id) 2001-08-16
DE69931904T2 (de) 2006-12-21
IS5656A (is) 2000-10-11
CY1105154T1 (el) 2010-03-03
PT1069890E (pt) 2006-09-29
ES2267268T3 (es) 2007-03-01
TR200002960T2 (tr) 2000-12-21
CZ20003784A3 (cs) 2001-08-15
HUP0102305A3 (en) 2003-04-28
NZ507190A (en) 2002-02-01
CN1309555A (zh) 2001-08-22
CN1201728C (zh) 2005-05-18
BR9909636A (pt) 2000-12-19

Similar Documents

Publication Publication Date Title
SE9801287D0 (sv) Incorporation of active substances in carrier matrixes
DE59602458D1 (de) Vorrichtung zur applikation von verbindungsmaterialdepots
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
EP0667700A3 (en) Method and device for echo cancellation using the "fast projection scheme".
BR9608723A (pt) Dispositivo de inalação e processo de dispersar uma substância ativa para inalação
ES2143500T3 (es) Metodo y aparato para comunicar señales.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DE69114649D1 (de) In-line Gas/Flüssigkeitsdispersion.
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
DE69402624D1 (de) Vorrichtung zur Lieferung von Hochdruckgas
PT824366E (pt) Sistema de tratamento e efluentes
DE3676148D1 (de) Antigerinnungsmittel, verfahren zu seiner herstellung und dieses mittel als wirkender grundstoff enthaltende antikoagulantia.
DE59610469D1 (de) Vorrichtung zur Verabreichung von Substanzen, insbesondere Inhalationspräparate
AP9901607A0 (en) Method and apparatus for continuous flow isoelectric focusing for
DE69620854D1 (de) Vorrichtung zum schrittweise Zuführen sowie Lochen von blattförmigen Materialien
ATE354544T1 (de) Verhinderung des zellwachstums in einem gewässer
FI940575A0 (fi) Tiivistystekniikka
AU7501996A (en) Testing of fluid systems
NO307368B1 (no) Fremgangsmåte for innkapsling av et vannoppløselig stoff i en gjærcelle
FR2664671B1 (fr) Vanne et dispositif de distribution multivoies, notamment pour fluides corrosifs.
DE59300758D1 (de) Vorrichtung zur Gaseintragung in Flüssigkeiten.
GR940100467A (el) Συστημα εκτελεσης ανοσοπροσδιορισμων σε βιολογικα υγρα ανθρωπων ζωων και φυτων με τριχοειδη σωληναρια.
ES2175101T3 (es) Sistema de carga de tejido para dispositivos biologicos implantables.
DE69023327D1 (de) Ablöseentwicklungsverfahren und Vorrichtung zur Durchführung.
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya